189 related articles for article (PubMed ID: 7546685)
1. Patterns of visual loss associated with pituitary macroadenomas.
Poon A; McNeill P; Harper A; O'Day J
Aust N Z J Ophthalmol; 1995 May; 23(2):107-15. PubMed ID: 7546685
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.
Cennamo G; Auriemma RS; Cardone D; Grasso LF; Velotti N; Simeoli C; Di Somma C; Pivonello R; Colao A; de Crecchio G
Eye (Lond); 2015 Jun; 29(6):797-802. PubMed ID: 25853400
[TBL] [Abstract][Full Text] [Related]
3. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
[TBL] [Abstract][Full Text] [Related]
4. Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968-1987.
Sullivan LJ; O'Day J; McNeill P
J Clin Neuroophthalmol; 1991 Dec; 11(4):262-7. PubMed ID: 1838546
[TBL] [Abstract][Full Text] [Related]
5. [Neuro-ophthalmological alternations in patients with pituitary adenomas and intrasellar arachnoidocele].
Cáceres M; Márquez M; Sánchez-Ramos M
Rev Neurol; 1998 Jun; 26(154):954-6. PubMed ID: 9658466
[TBL] [Abstract][Full Text] [Related]
6. Frequency doubling perimetry in patients with mild and moderate pituitary tumor-associated visual field defects detected by conventional perimetry.
Monteiro ML; Moura FC; Cunha LP
Arq Bras Oftalmol; 2007; 70(2):323-9. PubMed ID: 17589707
[TBL] [Abstract][Full Text] [Related]
7. Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.
Jayaraman M; Ambika S; Gandhi RA; Bassi SR; Ravi P; Sen P
Doc Ophthalmol; 2010 Dec; 121(3):197-204. PubMed ID: 20821036
[TBL] [Abstract][Full Text] [Related]
8. [Adenoma of the pituitary gland in the ophthalmologist's out-patient practice].
Kochánová I; Stasek A; Kubena T
Cesk Slov Oftalmol; 2004 Sep; 60(5):348-55. PubMed ID: 15566223
[TBL] [Abstract][Full Text] [Related]
9. Stages of improvement in visual fields after pituitary tumor resection.
Kerrison JB; Lynn MJ; Baer CA; Newman SA; Biousse V; Newman NJ
Am J Ophthalmol; 2000 Dec; 130(6):813-20. PubMed ID: 11124302
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Analysis of the Displacement of the Anterior Visual Pathway by Pituitary Lesions and the Associated Visual Field Loss.
Boland MV; Lee IH; Zan E; Yousem DM; Miller NR
Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3576-80. PubMed ID: 27388050
[TBL] [Abstract][Full Text] [Related]
11. Compression of the prechiasmatic optic nerve produces a junctional scotoma.
Karanjia N; Jacobson DM
Am J Ophthalmol; 1999 Aug; 128(2):256-8. PubMed ID: 10458197
[TBL] [Abstract][Full Text] [Related]
12. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
Hajiabadi M; Alimohamadi M; Fahlbusch R
World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
[TBL] [Abstract][Full Text] [Related]
13. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
[TBL] [Abstract][Full Text] [Related]
14. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study.
Feldkamp J; Santen R; Harms E; Aulich A; Mödder U; Scherbaum WA
Clin Endocrinol (Oxf); 1999 Jul; 51(1):109-13. PubMed ID: 10469480
[TBL] [Abstract][Full Text] [Related]
15. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
16. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
17. The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.
Lachowicz E; Lubiński W
Doc Ophthalmol; 2018 Dec; 137(3):193-202. PubMed ID: 30374652
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
Monteiro ML; Zambon BK; Cunha LP
Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
[TBL] [Abstract][Full Text] [Related]
19. [Ocular findings in pituitary adenoma].
Jin CH
Zhonghua Yan Ke Za Zhi; 1992 Sep; 28(5):293-5. PubMed ID: 1338589
[TBL] [Abstract][Full Text] [Related]
20. The pattern of visual impairment in patients with pituitary adenoma.
Wang H; Sun W; Fu Z; Si Z; Zhu Y; Zhai G; Zhao G; Xu S; Pang Q
J Int Med Res; 2008; 36(5):1064-9. PubMed ID: 18831902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
